BofA is spending big on GLP-1’s and AI invents a virus not found in nature for the first time
Bank of America spent $250 million on GLP-1 weight loss drugs for employees, calling it a moral imperative despite rising costs and workplace tensions. Meanwhile, AI-designed viruses created in a Stanford lab signal a breakthrough in synthetic biology with both medical promise and biosecu
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Products & Tools
Topics
Listen to This Episode
More from Morning Brew Daily
SpaceX’s AI Spending Rattles Investors & Influencers Blasted for Attending OpenAI’s Summer Camp
Got Ozempic Breath? & Goblins Infiltrate ChatGPT
Did Moderna Just Cure Cancer? & Freight Trains Have a $200M Theft Problem
Remote Work is Hurting Gen Z & Whey Protein is Facing a Shortage
Nvidia Buys Hugging Face for $12.9B & Pharma Companies are Bullish on Baldness
25-Year Old AI Hedge Fund Prodigy Wiped Out & Jersey Mike’s Goes Public
Related episodes
From other shows on similar topics.
AI goes IPO
Today, Explained
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze
All-In with Chamath, Jason, Sacks & Friedberg
$10M Business ideas w/ The Most Interesting Guy In Tech
My First Million
Hot I.P.O Summer + What Is A.I. Doing to Math? + HatGPT
Hard Fork
D.A. Wallach Explains Why Biotech VC Is So Different
Odd Lots
The great decoupling
Marketplace
Get summaries like this every morning.
Free AI-powered recaps of Morning Brew Daily and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.